Lp (a) -IN-5
Lp (a) -IN-5 (Compound A) is an orally active lipoprotein (a) (Lp (a) ) inhibitor. Lp (a) -IN-5 inhibits the assembly of Apo (a) and ApoB proteins with an IC50 value of 0.41 nM. Lp (a) -IN-5 is promising for research of diseases related to elevated plasma Lp (a) levels, such as cardiovascular diseases[1].
Product Specifications
CAS Number
2924841-79-0
UNSPSC
12352211
Target
Apolipoprotein
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Smiles
O=C(O)[C@H]([C@H]1CCNC1)CC2=CC=CC(CN(CC3=CC(C[C@H](C(O)=O)[C@H]4CCNC4)=CC=C3)CCOC5=CC(C[C@H](C(O)=O)[C@H]6CCNC6)=CC=C5)=C2
Molecular Formula
C43H56N4O7
Molecular Weight
740.93
References & Citations
[1]Yao JQ, et al. Crystal form of lipoprotein compound and preparation method therefor. WO2024230805A1. 2024-11-14.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MART-1 / Melan-A (M2-7C10), CF594 conjugate, 0.1mg/mL
P21 / WAF1 (WA-1), CF647 conjugate, 0.1mg/mL
MUC18 / Mucin 18 / CD146 (OJ79c), CF640R conjugate, 0.1mg/mL
CD50 (ICAM-3) (186-2G9), CF568 conjugate, 0.1mg/mL
Fibronectin (TV-1), CF594 conjugate, 0.1mg/mL
